Related Experiment Video
Updated: Aug 21, 2025
Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Ginsenoside Rg1 in neurological diseases: From bench to bedside
Shao-Jie Yang1, Jing-Ji Wang2, Ping Cheng1
1Key Laboratory of Xin'an Medicine, the Ministry of Education and Key Laboratory of Molecular Biology (Brain diseases), Anhui University of Chinese Medicine, Hefei, 230012, China.
Ginsenoside Rg1, a compound from ginseng, shows potential in treating brain disorders like dementia and depression by regulating stress responses, brain cell connections, and gut bacteria. Further research and clinical trials are needed to fully understand its therapeutic benefits.
Area of Science:
- Neuroscience
- Pharmacology
- Traditional Chinese Medicine
Background:
- Ginseng has a long history of use in traditional Chinese medicine.
- Ginsenoside Rg1, an active component of ginseng, possesses anti-inflammatory, antioxidant, and neuroprotective properties.
- Rg1 is being investigated for its therapeutic potential in neurological and psychiatric disorders, particularly dementia and depression.
Purpose of the Study:
- To review the current research on the mechanisms by which ginsenoside Rg1 ameliorates depression-like behaviors and its potential in treating Alzheimer's disease.
- To explore Rg1's effects on the hypothalamic-pituitary-adrenal (HPA) axis, synaptic plasticity, and gut microbiota.
- To discuss the implications of Rg1 for drug development and future clinical trials.
Main Methods:
- Literature review of studies investigating ginsenoside Rg1's effects on depression and Alzheimer's disease models.
- Analysis of Rg1's impact on HPA axis activity, synaptic plasticity, and gut flora.
- Evaluation of Rg1's neuroprotective effects, including dendrite and axon repair and modulation of neuroinflammation.
Main Results:
- Rg1 demonstrates efficacy in ameliorating depression-like behaviors through mechanisms including HPA axis inhibition, synaptic plasticity regulation, and gut flora modulation.
- Rg1 shows potential for alleviating Alzheimer's disease in various stages by repairing neural structures and reducing neuroinflammation.
- Rg1 may help regulate memory imbalances, specifically the interplay between working and aversive memory.
Conclusions:
- Ginsenoside Rg1 holds significant potential for treating neuropsychiatric disorders like depression and dementia.
- Further in-depth mechanistic investigations and targeted clinical trials are essential for advancing Rg1 as a therapeutic agent.
- Optimizing Rg1's permeability and bioavailability is crucial for its successful drug development.
